Search

Your search keyword '"Locker, G. J."' showing total 111 results

Search Constraints

Start Over You searched for: Author "Locker, G. J." Remove constraint Author: "Locker, G. J."
111 results on '"Locker, G. J."'

Search Results

1. Abstract

8. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

25. Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients.

28. Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

30. Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients

31. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2

33. [Long-term use of an endovascular temperature catheter].

34. Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experience.

35. Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage.

36. [Sepsis in hemato-oncologic patients].

37. Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trial.

38. Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.

39. Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.

40. Decrease of circulating hematopoietic progenitor cells During interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion.

41. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.

42. Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group.

43. Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.

44. Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinoma.

45. Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

46. [Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)].

47. Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactions.

48. Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders.

49. Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava.

50. Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?

Catalog

Books, media, physical & digital resources